AZAFLUNEX 137 micrograms/50 micrograms, suspension for spraying nasal bottle, 23 g
Active ingredients: Azelastine hydrochloride, Fluticasone propionate
Commercialized according to BDPMDispensing in France: Prescription only
Suspension for sprayingbottle, 23 gnasale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- AZAFLUNEX 137 microgrammes/50 microgrammes, suspension pour pulvérisation nasale
- Pharmaceutical form
- suspension pour pulvérisation
- Route of administration
- nasale
- Presentation description
- 1 flacon en verre brun de 23 g (120 pulvérisations) avec pompe doseuse et applicateur nasal (polypropylène)
- Marketing authorisation holder
- MEDYNEX
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 15 Sept 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65725797CIP73030053CIP133400930300534Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE D'AZÉLASTINEsuspension | 137 microgrammes · une pulvérisation | SA |
| PROPIONATE DE FLUTICASONEsuspension | 50 microgrammes · une pulvérisation | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.